| CRISPR Medicine | This is an overview of our interviews
A team of academic and industry scientists have developed and delivered what may be the world’s first mRNA-based, patient-specific CRISPR therapy for...
Scientists have significantly expanded the CRISPR-Cas9 toolbox by combining high-throughput protein engineering with machine learning to create...
Rather than correcting the main mutation that causes the disease, Italian researchers restored CFTR function by inserting naturally occurring,...
CRISPR Medicine News spoke with the four CRISPRMED25 poster prize winners to learn more about their research.
The small molecule AZD7648 has shown striking potential to enhance HDR in CRISPR editing, raising hopes for clinical translation. But a closer look by...
Scientists used lipid nanoparticles to deliver CRISPR-Cas9 targeting Hao1 for the treatment of primary hyperoxaluria type 1. Proof-of-concept studies...
Boston- and Germany-based biotech startup AIRNA is pioneering a new approach to genetic medicine by harnessing the body's natural RNA-editing...
CRISPRMED25 is an event not to be missed, but don't take it from us! Hear what some of CRISPRMED24 attendees have to say about the conference in this...
